当前位置: 首页 > 期刊 > 《中国现代医生》 > 2017年第10期
编号:13058842
瑞舒伐他汀对动脉粥样硬化性心血管疾病调脂能力的研究(4)
http://www.100md.com 2017年4月5日 《中国现代医生》 2017年第10期
     [14]Biswas N,Sangma MA.Serum LDL(Low Density Lipoprotein)As a Risk Factor for Ischemic Stroke[J]. Mymensingh Med J,2016,25(3):425-432.

    [15]Tsivgoulis G,Katsanos AH,Sharma VK,et al.Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke[J]. Neurology,2016,86(12): 1103-1111.

    [16]Takayama T,Komatsu S,Ueda Y,et al.Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on coronary plaque determined by angioscopy and intravascular ultrasound in Japanese with stable angina pectoris(from the aggressive lipid-lowering treatment approach using intensive rosuvastatin for vulnerable coronary artery plaque[ALTAIR] randomized trial)[J].Am J Cardiol,2016,117(8):1206-1212.

    [17]Sillesen H.Statins and their use in preventing carotid disease[J].Curr Atheroscler Rep, 2009,11(4):309-314.

    [18]Weeks DL,Greer CL,Willson MN.Statin medication use and nosocomial infection risk in the acute phase of stroke[J].J Stroke Cerebrovasc Dis,2016,25(10):2360-2367.

    [19]Panes O,González C,Hidalgo P,et al.Platelet tissue factor activity and membrane cholesterol are increased in hypercholesterolemia and normalized by rosuvastatin,but not by atorvastatin[J].Atherosclerosis,2016,257:164-171.

    [20]Kata D,F?觟ldesi I,Feher LZ,et al.Rosuvastatin enhances anti-inflammatory and inhibits pro-inflammatory functions in cultured microglial cells[J].Neuroscience,2016, 314:47-63.

    (收稿日期:2017-02-14), http://www.100md.com(柯博熙 陆蓉)
上一页1 2 3 4